HomeAI · summaries
Storia in 3 fonti
Cohance Lifesciences investing $18 million in NJ Bio, Aruka Bio to sharpen focus on ADC
Cohance Lifesciences invests $18 million in NJ Bio and Aruka Bio to enhance its antibody-drug conjugate strategy and partnerships.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Cohance Lifesciences invests $18 million to strengthen ADC strategy
Cohance Lifesciences will invest $18 million in NJ Bio and Aruka Bio, raising its NJ Bio stake to 67.3% and acquiring 65% of Aruka Bio.
- ·
economictimes.indiatimes.com
Cohance Lifesciences to invest USD 18 mn in NJ Bio, Aruka Bio
Cohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thirteen million dollars for NJ Bio,…
